RhMannioside A
CAS : 81720-05-0
Ref. 3D-FR74132
2mg | Arrêté | ||
5mg | Arrêté | ||
10mg | Arrêté | ||
20mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté |
Informations sur le produit
RhMannioside A is a capsicum annuum extract that has been shown to be effective in the treatment of chronic prostatitis. The extract contains 2% RhMannioside A, which has been shown to inhibit protein synthesis in the prostate gland and reduce symptoms of prostatitis. RhMannioside A can be used as an active ingredient in medicines for women with hormone-related cancers, such as breast cancer or ovarian cancer. It also has an anti-inflammatory effect and is able to reduce the size of tumors by blocking protein synthesis. RhMannioside A can be prepared using gel chromatography and chinese medicine preparation.